Court Rules RAW Rolling Papers Are Not “Drug Paraphernalia”

The United States Court of Appeals for the Ninth Circuit has ruled that RAW rolling papers are not considered “drug paraphernalia” under the Controlled Substances Act.

The ruling upheld a prior ruling in favor of HBI International, in its ongoing dispute with Central Coast Agriculture, Inc. The court denied Central Coast Agriculture’s petition for a full court rehearing, sustaining the original decision by a three-judge panel. This decision marks a significant moment in the trademark conflict over the “RAW” and “Raw Garden” trademarks.

On July 26, 2024, the ruling reaffirmed that BBK’s RAW rolling papers are not considered “drug paraphernalia” under the Controlled Substances Act, a claim previously contested by Central Coast Agriculture. The refusal to rehear the case leaves the lower court’s decision in favor of BBK unchanged.

“This outcome reaffirms our commitment to protecting our business interests and upholding the integrity of our operations,” said a BBK spokesperson. “We will continue to focus on providing high-quality products to our customers while defending our rights in the legal arena.”

The dispute began when BBK Tobacco & Foods LLP, known for its RAW-branded smoking products, alleged that Central Coast Agriculture’s use of the “Raw Garden” trademark for its cannabis products infringed on BBK’s trademarks. BBK’s lawsuit included allegations of trademark infringement and sought to cancel several of CCA’s trademark applications, citing a lack of bona fide intent to use the mark in commerce.

In April 2024, the Ninth Circuit confirmed the district court’s authority to consider challenges to trademark applications within the context of an action involving a registered trademark. The court determined that CCA’s intent-to-use applications for the “Raw Garden” trademark lacked bona fide intent, supporting BBK’s claims.

BBK’s legal strategy has seen several key moves. Initially, the district court dismissed BBK’s false advertising claims but granted summary judgment for BBK on its counterclaims to invalidate CCA’s trademark applications. The Ninth Circuit’s latest ruling not only supports this stance but also prevents further reconsideration by a larger panel of judges.

This ruling is significant for BBK, as it protects the integrity of its trademark and business practices. The company has consistently argued that its products, including RAW rolling papers, lighters, and tobacco grinders, are not “drug paraphernalia” and should not be classified as such under federal law.

This legal victory not only benefits BBK but also sets a precedent in the industry for the protection and enforcement of trademarks, emphasizing the necessity of bona fide intent to use trademarks in commerce within the competitive cannabis and smoking accessories market. The case highlights the complexities of trademark disputes, especially when intersecting with federal regulations on controlled substances.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

 

 

More articles from The Marijuana Herald can be found below.

Study: Long-Acting Injectable CBD Shows Weeks-Long Presence in Calves, Suggesting Possible Use for Painful Farm Procedures

Study: Long-Acting Injectable CBD Shows Weeks-Long Presence in Calves, Suggesting Possible Use for Painful Farm Procedures

Bacteria From Hemp Seed Oil Shown to Combat Botrytis, Offering a New Biocontrol Tool for Cannabis Growers

Bacteria From Hemp Seed Oil Shown to Combat Botrytis, Offering a New Biocontrol Tool for Cannabis Growers

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales